China 'No' For Celgene's Paclitaxel A Major Blow To BeiGene

Inspections Report 20% GMP Non-Compliance

 
• By Brian Yang

After winning a major procurement contract, BeiGene now may need to find an alternative manufacturing site for  Celgene's Abraxane to supply China.

production line
CHINA SUSPENDS CELGENE'S PACLITAXEL DUE TO GMP ISSUES • Source: Shutterstock

More from Manufacturing

More from Business